v3.26.3
Condensed Consolidated Statements of Cash Flows
$ in Millions
9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Cash flows – operating activities:      
Net loss $ (551) $ (5,982)  
Non-cash items –       
Share-based plans expense 361 343  
Treasury shares issued for 401(k) contributions 1,275 1,173  
Depreciation and amortization 1,753 1,417  
Investment/asset impairment charges, net 122 32  
Gain on dispositions, net (79) (63)  
777X and 767 reach-forward losses 86 5,140  
Other charges and credits, net (1) 217  
Changes in assets and liabilities –       
Accounts receivable (1,130) (836)  
Unbilled receivables (1,039) (679)  
Advances and progress billings 8,113 (2,065)  
Inventories (6,733) (116)  
Other current assets (127) 227  
Accounts payable 2,436 539  
Accrued liabilities (1,562) 574  
Income taxes receivable, payable and deferred (76) 93  
Other long-term liabilities (148) (294)  
Pension and other postretirement plans (86) (436)  
Financing receivables and operating lease equipment, net (112) 274  
Other 179 176  
Net cash provided/(used) by operating activities 2,681 (266)  
Cash flows – investing activities:      
Payments to acquire property, plant and equipment (3,040) (1,986)  
Proceeds from disposals of property, plant and equipment 21 5  
Proceeds from dispositions 35  
Contributions to investments (28,170) (36,337)  
Proceeds from investments 35,040 32,674  
Supplier notes receivable (11) (292)  
Repayments on supplier notes receivable 12  
Other 1  
Net cash provided/(used) by investing activities 3,853 (5,901)  
Cash flows – financing activities:      
New borrowings 46 138  
Debt repayments (8,415) (721)  
Employee taxes on certain share-based payment arrangements (38) (28)  
Dividends paid on Mandatory convertible preferred stock (259) (244)  
Other 46 43  
Net cash used by financing activities (8,620) (812)  
Effect of exchange rate changes on cash and cash equivalents 5 39  
Net decrease in cash & cash equivalents, including restricted (2,081) (6,940)  
Less net decrease in cash & cash equivalents classified as Assets held for sale    
Cash & cash equivalents, including restricted, at beginning of year 11,663 13,822  
Cash & cash equivalents, including restricted, at end of period 9,541 6,882  
Less restricted cash & cash equivalents, included in Investments 43 709  
Cash and cash equivalents at end of period $ 9,498 $ 6,173